Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against ...

Indiana University said it found plagiarism allegations against Pamela Whitten to be without merit. Experts and scholars ...

Pharmaceuticals, medical and laboratory products distributor Cardinal Health will open a new distribution center in Fort Worth, TX. The 340,000-square-foot facility will support the company’s at-Home ...

Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...

Canadians Cardinal Michael Czerny and sculptor Timothy P. Schmalz on Thursday in Rome spoke about evangelization through art as part of festivities linked to the Jan. 24–26 Jubilee of the World ...

Cardinal Christoph Schönborn, OP, concluded his term as archbishop of Vienna, Austria, on Wednesday, his 80th birthday, when Pope Francis accepted his resignation. Schönborn, a theologian who ...

Proper storage of medical products is critical due to their potential sensitivity to environmental conditions, such as ...